opioid crisis

Showing 15 posts of 81 posts found.

Pharma on Facebook

Facebook unveils new feature to battle opioid crisis

June 20, 2018
Medical Communications, Research and Development, Sales and Marketing FDA, Facebook, US, opioid crisis, opioids, pharma

Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing …

facilities_lg06

Dr Reddy’s just-approved opioid dependence generic blocked over US patent dispute

June 18, 2018
Sales and Marketing Dr Reddy's, FDA, Mylan, US, opioid crisis, opioid dependence, opioids, suboxone

Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) …

512px-kratom_leaves_3

FDA reprimands suppliers of opioid substitute kratom products

May 23, 2018
Research and Development, Sales and Marketing FDA, kratom, opioid crisis, opioids, pharma

The ongoing opioid epidemic in the US has seen the rise of the sale and use of kratom (mitragyna speciose), …

opioid_therapy_credit_-_us_air_force_valerie_monroy

FDA green lights first non-opioid therapy to manage symptoms of opioid withdrawal

May 17, 2018
Sales and Marketing FDA, Lucemyra, opioid crisis, opioids, pharma

As the opioid epidemic continues to grip the US as the leading cause of deaths in those under the age …

opioid_therapy_credit_-_us_air_force_valerie_monroy

Los Angeles becomes latest US city to sue pharma over opioid crisis

May 4, 2018
Medical Communications, Sales and Marketing Los Angeles, opioid crisis, pharma

The city of Los Angeles has levied legal action against a number of pharmaceutical firms for their role in advancing …

shutterstock_38078521

Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3

March 20, 2018
Manufacturing and Production, Research and Development heron therapeutics, opioid crisis, opioid epidemic, opioids, painkiller, pharma

Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary …

opioid_therapy_credit_-_us_air_force_valerie_monroy

Opioids are no more effective than common painkillers, study reveals

March 8, 2018
Medical Communications, Research and Development US, opioid crisis, opioids, pharma

A team of researchers at the Minneapolis Veterans Affairs Health Care System has found that, for all their risks, opioids …

opioid_crisis

FDA to fight opioid crisis with wider access to medication-assisted treatment

February 27, 2018
Manufacturing and Production, Medical Communications, Research and Development Alex Azar, FDA, medication-assisted treatment, opioid crisis, opioids, pharma

The FDA is set to refocus its efforts in combating the United States’ opioid crisis. Speaking at a meeting of …

shutterstock_138095450

New York City launches $500 million lawsuit against big pharma over opioid crisis

January 24, 2018
Research and Development, Sales and Marketing New York City, opioid crisis, opioids, pharma

The administration of New York City Mayor Bill de Blasio has announced its intention to bring legal action against the …

opioid_crisis

FDA approves first and only therapy of its kind for opioid addiction

December 1, 2017
Medical Communications, Sales and Marketing FDA, Invidior, Sublocade, US, opioid crisis, opioids, pharma

Image Credit:  Marco VerchAs the US languishes in the midst of an opioid crisis which President Trump declared national emergency …

shutterstock_95714119

Children are still prescribed codeine despite FDA warnings, study finds

November 20, 2017
Medical Communications, Research and Development, Sales and Marketing US, codeine, opioid crisis, opioids, pharma

A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …

Indivior’s opioid addiction treatment recommended by FDA advisory panel

November 1, 2017
Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids

Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …

shutterstock_138095450

Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl

October 27, 2017
Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids

John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …

Latest content